Search results
Roche (RHHBY) Announces 2-Year Data on Vabysmo for nAMD
Zacks via Yahoo Finance· 2 years agoRoche RHHBY has announced new two-year data from the TENAYA and LUCERNE studies on ophthalmology...
Roche's (RHHBY) Vabysmo Gets Approval for nAMD & DME in Europe
Zacks via Yahoo Finance· 2 years agoThe European Commission approves Roche's (RHHBY) Vabysmo for treating neovascular or wet age-related...
Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study
Zacks via Yahoo Finance· 8 months agoRoche's (RHHBY) stock jumps 4.3% on Wednesday after the company inadvertently publishes encouraging...
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating...
Roche (RHHBY) 1H22 Earnings, Sales Grow, View Disappoints
Zacks via Yahoo Finance· 2 years agoRoche (RHHBY) performance in the first half was decent on demand for its diagnostics base business...
Pharma Stock Roundup: RHHBY's Alzheimer's Study Failure, EU Nod for SNY's Enjaymo
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) late-stage Alzheimer's disease study on key pipeline candidate, gantenerumab fails....
Should You Hold Roche Holding AG (RHHBY)?
Insider Monkey via Yahoo Finance· 11 months agoHarding Loevner, an asset management company, released its “International Equity Strategy” first-quarter 2023 investor letter. A copy of the same can be...
Roche's (RHHBY) Lunsumio Application Gets Priority Review
Zacks via Yahoo Finance· 2 years agoRoche's (RHHBY) BLA application seeking approval for the use of Lunsumio for relapsed or refractory...
Roche (RHHBY) 2023 Earnings Miss, COVID-19 Product Sales Down
Zacks via Yahoo Finance· 3 months agoRoche (RHHBY) misses earnings and sales estimates in 2023 due to a significant decline in...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 5 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
